Ewurabena Simpson

518 total citations
19 papers, 352 citations indexed

About

Ewurabena Simpson is a scholar working on Hematology, Genetics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Ewurabena Simpson has authored 19 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 7 papers in Genetics and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Ewurabena Simpson's work include Hemoglobinopathies and Related Disorders (7 papers), Adolescent and Pediatric Healthcare (3 papers) and Prenatal Screening and Diagnostics (3 papers). Ewurabena Simpson is often cited by papers focused on Hemoglobinopathies and Related Disorders (7 papers), Adolescent and Pediatric Healthcare (3 papers) and Prenatal Screening and Diagnostics (3 papers). Ewurabena Simpson collaborates with scholars based in Canada, United States and United Kingdom. Ewurabena Simpson's co-authors include Louise Pilote, Hugues Richard, Yulia Lin, Chris Hyde, Carolyn Dorée, Janet Birchall, Simon Stanworth, Mark J. Eisenberg, Christine A. Beck and Leonardo R. Brandão and has published in prestigious journals such as Blood, Cochrane Database of Systematic Reviews and American Heart Journal.

In The Last Decade

Ewurabena Simpson

18 papers receiving 340 citations

Peers

Ewurabena Simpson

CCM

HEMAT

SURGE

CCICM

Alexander Nagrebetsky United States

Laura K. Evenson United States

Lisa Cooper Israel

Devin Horton United States

David Anderson Australia

Kerri Gallo Canada

Aisha Bruce Canada

H.-C. Chen Taiwan

Elizabeth C. Wilson United States

Qing Harshaw United States

Alexander Nagrebetsky United States

Ewurabena Simpson

121 ×1.0

CCM

37 ×0.5

HEMAT

139 ×2.0

SURGE

6 ×0.1

26 ×0.4

CCICM

Citations per year, relative to Ewurabena Simpson Ewurabena Simpson (= 1×) peers Alexander Nagrebetsky

Countries citing papers authored by Ewurabena Simpson

Since Specialization

Citations

This map shows the geographic impact of Ewurabena Simpson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ewurabena Simpson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ewurabena Simpson more than expected).

Fields of papers citing papers by Ewurabena Simpson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ewurabena Simpson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ewurabena Simpson. The network helps show where Ewurabena Simpson may publish in the future.

Co-authorship network of co-authors of Ewurabena Simpson

This figure shows the co-authorship network connecting the top 25 collaborators of Ewurabena Simpson. A scholar is included among the top collaborators of Ewurabena Simpson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ewurabena Simpson. Ewurabena Simpson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Nair, Anand R., Melanie Kirby‐Allen, Ewurabena Simpson, et al.. (2025). A pilot randomized controlled trial of the iPeer2Peer program in adolescents with sickle cell disease: A mixed method study. Journal of Clinical and Translational Science. 9(1). e18–e18. 2 indexed citations

Deguise, Marc‐Olivier, et al.. (2023). Congenital dyserythropoietic anemia type IV in the genetic era: A rare neonatal case report of rapid identification with a review of the literature. Pediatric Blood & Cancer. 70(5). e30245–e30245. 2 indexed citations

Jaremko, Jacob L., Aisha Bruce, Nathalie Alos, et al.. (2022). Sickle cell bone disease and response to intravenous bisphosphonates in children. Osteoporosis International. 33(11). 2397–2408. 9 indexed citations

Bauman, Mary, Rukhmi Bhat, Ewurabena Simpson, et al.. (2022). Online KidClot education for patients and families initiating warfarin therapy: The eKITE study. Thrombosis Research. 215. 14–18. 2 indexed citations

Khangura, Sara D., Beth K. Potter, Christine Davies, et al.. (2021). Health services use by children identified as heterozygous hemoglobinopathy mutation carriers via newborn screening. BMC Pediatrics. 21(1). 296–296. 1 indexed citations

Kulkarni, Ketan, et al.. (2021). A pilot feasibility and safety multicenter trial of administering weight adjusted FiXED dose of low molecular weight heparin (ENOXAPARIN) to neonates and children with thrombosis. 2(2). e0053–e0053.

Alanazi, Abdullah, et al.. (2020). Neonates with Asymptomatic Central Venous Catheter-Related Thrombosis - a Systematic Review. Blood. 136(Supplement 1). 8–9. 1 indexed citations

Lalloo, Chitra, Richard Ward, William T. Zempsky, et al.. (2018). Exploring the Needs of Adolescents With Sickle Cell Disease to Inform a Digital Self-Management and Transitional Care Program: Qualitative Study. JMIR Pediatrics and Parenting. 1(2). e11058–e11058. 23 indexed citations

Tole, Soumitra, et al.. (2018). Reassessing the Need for Pre-Operative Transfusions in Sickle Cell Disease Patients with a High Baseline Hemoglobin. Blood. 132(Supplement 1). 2370–2370. 1 indexed citations

10.

Simpson, Ewurabena, Robert J. Klaassen, Pranesh Chakraborty, et al.. (2018). Increasing Incidence and Prevalence of Pathologic Hemoglobinopathies Among Children in Ontario, Canada from 1991-2013. Blood. 132(Supplement 1). 4698–4698. 2 indexed citations

11.

Ward, Richard, Ewurabena Simpson, & Madeleine Verhovsek. (2016). A 19-year-old woman with sickle cell disease and pain. Canadian Medical Association Journal. 188(10). 745–746. 1 indexed citations

12.

Johnston, Donna L., Jacqueline Halton, Mylène Bassal, et al.. (2016). Pediatric Oncology Clinic Care Model: Achieving Better Continuity of Care for Patients in a Medium-sized Program. Journal of Pediatric Hematology/Oncology. 39(6). 476–480. 1 indexed citations

13.

Simpson, Ewurabena, Yulia Lin, Simon Stanworth, et al.. (2012). Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia. Cochrane Database of Systematic Reviews. 2012(4). 114 indexed citations

14.

Brandão, Leonardo R., Ewurabena Simpson, & Keith K. Lau. (2011). Neonatal renal vein thrombosis. Seminars in Fetal and Neonatal Medicine. 16(6). 323–328. 35 indexed citations

15.

Simpson, Ewurabena, Richard Ward, Melanie Kirby, & Isaac Odame. (2011). Comparing Patterns for Transitioning the Care of Young Adults with Sickle Cell Disease Versus Hemophilia: The Toronto Experience. Blood. 118(21). 2072–2072. 3 indexed citations

16.

Simpson, Ewurabena & Louise Pilote. (2005). Quality of life after acute myocardial infarction: A comparison of diabetic versus non-diabetic acute myocardial infarction patients in Quebec acute care hospitals. Health and Quality of Life Outcomes. 3(1). 80–80. 29 indexed citations

17.

Simpson, Ewurabena, Christine A. Beck, Hugues Richard, Mark J. Eisenberg, & Louise Pilote. (2003). Drug prescriptions after acute myocardial infarction: Dosage, compliance, and persistence. American Heart Journal. 145(3). 438–444. 92 indexed citations

18.

Simpson, Ewurabena & Louise Pilote. (2003). Quality of life after acute myocardial infarction: a systematic review.. PubMed. 19(5). 507–11. 21 indexed citations

19.

Simpson, Ewurabena, et al.. (2002). Regional variation in the management of acute myocardial infarction in the province of Quebec.. PubMed. 18(10). 1067–76. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact